Excedrin Migraine has been the OTC migraine standard for decades — a triple-action combo of acetaminophen + aspirin + caffeine. Plopii’s Migraine Pill keeps the analgesic foundation and swaps the caffeine for paraxanthine: designed for faster onset, less rebound, and less afternoon crash. Excedrin Migraine is an FDA-approved OTC drug. Plopii Migraine Pill is an investigational combination being developed under the FDA's 505(b)(2) pathway and is not currently sold as an FDA-approved drug. Here’s how they line up ingredient-for-ingredient.
| Attribute | Plopii Migraine Pill | Excedrin Migraine |
|---|---|---|
| Acetaminophen (APAP) | 250mg | 250mg |
| Aspirin (ASA) | 250mg | 250mg |
| Stimulant adjuvant | Paraxanthine 75mg | Caffeine 65mg |
| Mechanism of stimulant | Adenosine antagonist, faster vasoconstriction, shorter half-life | Adenosine antagonist + caffeine’s metabolites including paraxanthine |
| Rebound headache risk | Lower — paraxanthine clears in ~3.4h vs caffeine 5-6h | Caffeine rebound headache is a documented risk with frequent use |
| Afternoon crash if taken AM | Minimal | Possible — 65mg caffeine still in system at 4-5pm |
| Sleep impact if taken PM | Lower | Higher |
| Onset of relief (clinical norms) | 30-60 min | 30-60 min |
| OTC availability | Investigational — not yet marketed | OTC (FDA-approved) |
| FDA status | Investigational — paraxanthine combination pursuing 505(b)(2) pathway; APAP and ASA doses match the established OTC monograph (21 CFR 343) | OTC monograph (21 CFR 343) |
If you take Excedrin Migraine and feel wired afterward — or if you avoid taking it past noon because of sleep — Plopii’s paraxanthine swap is engineered for exactly that problem: the same APAP + ASA analgesic foundation, with a cleaner stimulant adjuvant. Plopii Migraine Pill is investigational and not yet available; sign up to be notified when the regulatory pathway clears.
Shop Plopii Migraine PillNo. The acetaminophen and aspirin doses match the FDA OTC monograph (21 CFR 343) for analgesic combinations. Plopii substitutes paraxanthine for caffeine as the stimulant adjuvant; we are pursuing the appropriate regulatory pathway for this novel combination. It is not currently sold as an FDA-approved drug.
Combining stimulants is generally not recommended. If you’re using the pill for migraine, skip the coffee that morning.
Yes — same as Excedrin: avoid in children, in people with bleeding disorders, alcohol use disorder, NSAID sensitivity, late pregnancy, or active GI bleeding. Read the full label and consult a physician.
Comparison information is for educational purposes. These statements have not been evaluated by the FDA.